Maxim Group LLC Appoints Four Managing Directors in Equity Research Division
May 31, 2017 12:11 pm UTC| Business
NEW YORK, May 31, 2017 -- Maxim Group LLC, a leading full service investment banking, securities and wealth management firm, announced the appointment of four Managing Directors in the Equity Research Division: Brian...
Zogenix to Present at the Jefferies 2017 Global Healthcare Conference
May 31, 2017 12:10 pm UTC| Business
EMERYVILLE, Calif., May 31, 2017 -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that Michael P....
Zogenix to Present at the Jefferies 2017 Global Healthcare Conference
May 31, 2017 12:10 pm UTC| Business
EMERYVILLE, Calif., May 31, 2017 -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that Michael P....
Zogenix to Present at the Jefferies 2017 Global Healthcare Conference
May 31, 2017 12:10 pm UTC| Business
EMERYVILLE, Calif., May 31, 2017 -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that Michael P....
Zogenix to Present at the Jefferies 2017 Global Healthcare Conference
May 31, 2017 12:10 pm UTC| Business
EMERYVILLE, Calif., May 31, 2017 -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that Michael P....
Zogenix to Present at the Jefferies 2017 Global Healthcare Conference
May 31, 2017 12:10 pm UTC| Business
EMERYVILLE, Calif., May 31, 2017 -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that Michael P....
Zogenix to Present at the Jefferies 2017 Global Healthcare Conference
May 31, 2017 12:10 pm UTC| Business
EMERYVILLE, Calif., May 31, 2017 -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that Michael P....
India–US Trade Pact 2026: A New Highway to a USD 500 Billion Partnership